UNSPSC 51283903: Phthalylsulfathiazole

This classification denotes a sulfonamide anti-infective agent with the molecular formula C17H13N3O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6875L5852V, chemically known as sulfanilamide, n(sup 4)-(o-carboxybenzoyl)-n-2-thiazolyl- but generally known as phthalylsulfathiazole, which bears US NIH Compound Identifier 4806. European Medicines Agency schedules Phthalylsulfathiazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09799MIG.

UNSPSC 51283903 Phthalylsulfathiazole, a Commodity code, shows little relevant recent activity under its nominal scope. The recent opportunities tagged to this code—naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS Commission), fire department medical and first aid supplies (City of Tampa), and generic multi-source pharmaceuticals through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance)—are plainly unrelated to phthalylsulfathiazole, an antimicrobial pharmaceutical compound. State and local procurement databases appear to have miscoded these opportunities, conflating them with the UNSPSC code rather than classifying them under the appropriate pharmaceutical or medical-supply codes. The mismatch suggests that buyers and procurement systems are not consistently routing pharmaceutical-product solicitations to this Commodity code as currently configured.

The geographic spread of recent activity tagged to this code spans Florida, Texas, Minnesota, and Oregon, driven primarily by state health and human services agencies, municipal purchasing departments, and cooperative purchasing vehicles rather than use of the Commodity code itself as an organizing principle. Without evidence of actual procurement demand for phthalylsulfathiazole as a line item, the code should be treated as inactive or dormant for state and local opportunity monitoring purposes. Firms pursuing state and local pharmaceutical and medical-supply contracts would be better served monitoring higher-tier pharmaceutical and medical-supply codes and tracking cooperative purchasing RFPs such as MMCAP directly rather than relying on this Commodity code for lead generation.